51³Ô¹ÏÍø
Tag - moderna
Subscribe
Digital
Print
July 24, 2026
Subscribe
Digital
Print
Heat
Parliament
China
Latest News
Home Delivery
51³Ô¹ÏÍø
Politics
Society
Crime & Legal
Science & Health
Explainer
History
WORLD
Politics
Crime & Legal
Science & Health
Society
ASIA PACIFIC
Politics
Crime & Legal
Science & Health
Society
BUSINESS
Companies
Economy
Markets
Tech
SPORTS
Sumo
Soccer
Baseball
Basketball
Tennis
Olympics
More sports
OPINION
Editorials
Commentary
Geoeconomic Briefing
Environment
CLIMATE CHANGE
Energy
SUSTAINABILITY
WILDLIFE
EARTH SCIENCE
LIFE
Travel
Digital
Food & Drink
Style & Design
Language
Lifestyle
CULTURE
Film
Books
Music
Art
TV & Streaming
Stage
Entertainment news
COMMUNITY
Voices
Issues
How-tos
Our Lives
My Account
My Bookmarks
Logout
Subscribe for more access
MODERNA
WORLD
/
Science & Health
Jun 2, 2026
Moderna and other groups get $60 million to develop Ebola vaccine
Richard Hatchett, head of CEPI, said that it was possible to get Ebola Bundibugyo (BDBV) vaccines ready for trials within a couple of months.
COMMENTARY
/
Japan
May 2, 2025
RFK Jr.¡¯s new vaccine scrutiny is alarming
Robert F. Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn¡¯t possibly meet.
BUSINESS
Jul 6, 2023
Moderna signs deal with Shanghai to make mRNA vaccines for Chinese market
The Massachusetts-based company will work with local government to conduct clinical trials and apply to bring products to market as well as to produce them in China.
WORLD
/
Science & Health
Jun 6, 2023
Cancer vaccines poised to unlock ¡®new treatment paradigm¡¯ with Merck-Moderna data
Scientists have been chasing the dream of vaccines to treat cancer for decades with few successes.
COMMENTARY
/
World
Apr 21, 2023
Cancer vaccine hunt makes progress, finally
A small cancer drug study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling COVID-19.
WORLD
/
Science & Health
Apr 17, 2023
Moderna-Merck cancer vaccine plus Keytruda delays recurrence of skin cancer
The findings of the recent trial suggest that adding a personalized cancer vaccine to antibody-based immunotherapy could prolong the time patients have without death or the cancer¡¯s return.
COMMENTARY
/
World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma ¡ª but fighting tumors is vastly more complex than tackling COVID-19.
51³Ô¹ÏÍø
Sep 12, 2022
Japan health ministry backs Pfizer and Moderna omicron boosters
Pfizer¡¯s omicron booster can be administered to people age 12 and over, while Moderna¡¯s is limited to those 18 and above, the panel advised.
51³Ô¹ÏÍø
/
Science & Health
/
EXPLAINER
Aug 12, 2022
What we know about the new omicron vaccines
New vaccines developed for the COVID-19 omicron variant are scheduled to be available from mid-October in Japan, raising hopes that the population will soon be better protected.
51³Ô¹ÏÍø
Jun 3, 2022
Skin rash more common in women after Moderna shot, Japan study finds
Swelling, pain and/or itchiness of the arm that received the vaccine was also more common among people in their 30s through 60s.
COMMENTARY
/
World
Apr 11, 2022
We need better COVID-19 booster shots, not more of the same
There are 100 new Covid vaccines in development. One of them could offer better protection against omicron.
BUSINESS
/
Companies
Mar 23, 2022
With sumo flag sponsorship deal, COVID vaccine-maker Moderna reveals Japan ambition
The U.S. firm is seeking to build on its newfound renown in COVID-19 vaccines and wrestle market share from compatriot Pfizer Inc.
51³Ô¹ÏÍø
Feb 7, 2022
Japan¡¯s booster rollout is relying on Pfizer and Moderna. How do the shots compare?
Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as one is eligible, no matter which type, is key.
WORLD
Jan 27, 2022
Moderna starts trial for omicron-specific booster shot
The news comes a day after rival vaccine developer Pfizer Inc. launched a similar trial.
WORLD
/
Science & Health
Jan 16, 2022
The decades of discoveries before the ¡®miraculous¡¯ sprint to a vaccine
The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.
WORLD
/
Science & Health
Jan 11, 2022
Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate
While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac¡¯s and Sinopharm Group¡¯s shots, which have been widely used in the developing world.
51³Ô¹ÏÍø
/
Explainer
Jan 6, 2022
The ins and outs of Japan¡¯s COVID-19 booster shot rollout
Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what¡¯s the rationale behind that strategy?
WORLD
/
Science & Health
Dec 20, 2021
Moderna says its booster dose appears protective against omicron
The data, which has not yet been peer reviewed, tested blood from people who had received the vaccine against a pseudovirus engineered to resemble the omicron variant.
BUSINESS
Dec 14, 2021
Moderna to produce millions of mRNA vaccines in Australia
The deal underscores efforts by governments around the world to build up local production and prepare for future pandemic threats.
COMMENTARY
/
World
Dec 1, 2021
What¡¯s worst about omicron so far is the uncertainty
How should the world respond to omicron? We just have to wait as there is information that we don¡¯t yet have. And for many, the waiting itself is the problem.
? Prev
1
2
3
4
5
Next ?
WHAT¡¯S TRENDING
Editors' Picks
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
Indian brothers make manga debut in Japan
Japan weighs regulating Pokemon cards amid trading mania
Low-income families in Japan cut food and air conditioning during summer break
Iran strikes on CIA facilities prompt questions about possible Russian role
The sci-fi sensibilities of electronic trio Black Boboi
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
The 180-day locals: Life on Japan¡¯s digital nomad visa
Japan reveals hint of new defense spending target in fiscal blueprint
Podcast
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯
Longform
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By
Alex K.T. Martin
SUSTAINABLE 51³Ô¹ÏÍø
SPECIAL SUPPLEMENTS
Sponsored contents planned and edited by JT Media Enterprise Division.
SUPPLEMENTS BINDER